PREVALENCE OF OSTEOPENIA, OSTEOPOROSIS, AND ASSOCIATED FACTORS AMONG WOMEN AGED 40-60 YEARS WORKING AT THONG NHAT HOSPITAL IN 2025
Main Article Content
Abstract
Aims: To determine the prevalence of osteopenia and osteoporosis and to identify associated factors among women aged 40-60 years working at Thong Nhat Hospital.
Methods: A cross-sectional study was conducted among 131 women aged 40-60 years. Anthropometric measurements were obtained, bone mineral density (BMD) was measured by dual-energy X-ray absorptiometry (Hologic model Discovery Wi), and serum vitamin D concentrations were determined. Menopausal status was assessed through interviews. Osteopenia was defined as a T-score ≤ −1.0 at either total lumbar spine, total femoral or femoral neck, while osteoporosis was defined as a T-score ≤ −2.5 at either site.
Results: The prevalence of osteopenia and osteoporosis was 39,7% (95% CI: 31,7–48,3) and 6,1% (95% CI: 3,1–11,6), respectively. The overall prevalence of low bone mineral density was 45,8% (95% CI: 37,5–54,3). Obesity was present in 18,3% of participants, and 96,2% had serum 25-OH vitamin D levels below 30 ng/mL. In the multivariable model, age was independently associated with osteoporosis after adjustment for BMI. For every 5-year increase in age, the odds of osteoporosis increased 7,71-fold (OR = 7,71; 95% CI: 2,40–43,68; p < 0,001).
Conclusions: Low bone density and vitamin D insufficiency/deficiency are common among women aged 40-60 years. Age was independently associated with osteoporosis.
Keywords
Osteopenia, osteoporosis, women aged 40-60 years, body mass index, Vitamin D.
Article Details
References
1. Digital Science & Research Solutions, Inc. Consensus development conference: diagnosis, prophylaxis, and treatment of osteoporosis. Am J Med 1993; 94(6): 646–650.
2. Harvey N, Dennison E, Cooper C. Osteoporosis: impact on health and economics. Nat Rev Rheumatol 2010; 6(2): 99–105.
3. Ho-Pham LT, Nguyen TV. The Vietnam Osteoporosis Study: Rationale and design. Osteoporos Sarcopenia. 2017 Jun;3(2):90-97. doi: 10.1016/j.afos.2017.06.001. Epub 2017 Jun 13. PMID: 30775510; PMCID: PMC6372769.
4. Sözen T., Özışık L., Başaran N.Ç. An Overview and Management of Osteoporosis.Eur. J. Rheumatol.2017;4:46–56. doi:10.5152/eurjrheum.2016.048.
5. Lại Thị Thùy Dương (2023). Nghiên cứu thực trạng loãng xương ở phụ nữ sau mãn kinh đến khám tại khoa khám bệnh theo yêu cầu Bệnh viện Bạch Mai [Internet]. [được trích dẫn 26 Tháng Bảy 2026]. https://tapchiyhocvietnam.vn/index.php/vmj/article/view/6603/5890. Truy cập 26 thg 7 2026
6. Ho-Pham LT, et al. Longitudinal changes in bone mineral density during perimenopausal transition. Osteoporosis International. 2023.
7. Management of osteoporosis in postmenopausal women: the 2021 position statement of The North American Menopause Society. Menopause. 2021;28(9):973. doi:10.1097/GME.0000000000001831.
8. Shariati-Sarabi Z, Rezaie HE, Milani N, Rezaie FE, Rezaie AE. Evaluation of Bone Mineral Density in Perimenopausal Period. Arch Bone Jt Surg. 2018 Jan;6(1):57-62. PMID: 29430497; PMCID: PMC5799602.
9. Smeets-Goevaers CG, Lesusink GL, Papapoulos SE, Maartens LW, Keyzer JJ, Weerdenburg JP, Beijers LM, Zwinderman AH, Knottnerus JA, Pols HA, Pop VJ. The prevalence of low bone mineral density in Dutch perimenopausal women: the Eindhoven perimenopausal.